Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Beckman Agreement Will Give Biosite Automated Platform For BNP Assay

This article was originally published in The Gray Sheet

Executive Summary

Biosite will leverage Beckman Coulter's U.S. installed base of automated immunoassay analyzers to grow its market share in BNP testing under a long-term development deal between the firms
Advertisement

Related Content

Beckman Coulter Buys Cardiac Test Developer Biosite For $1.55 Billion
Beckman Coulter Buys Cardiac Test Developer Biosite For $1.55 Billion
BioSite Launches Triage Stroke Panel In Europe, Defends BNP Test Share
BioSite Launches Triage Stroke Panel In Europe, Defends BNP Test Share
Beckman Coulter Will Test Roche’s Lead In Routine Chemistry Market
Cardiac Markers Clash For Hospital, Lab Space: Biosite Triages R&D Projects
Roche Diagnostics Inks Second ProBNP Test Development Deal
Biosite Aims For 2004 Approval Of Triage For Ischemic, Hemorrhagic Stroke
Roche CHF Test Will Benefit From Reimbursement Advantages In 2003
Roche CHF Test Will Benefit From Reimbursement Advantages In 2003
Advertisement
UsernamePublicRestriction

Register

MT018610

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel